You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca has agreed to sell the global commercial rights to Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma. The agreement excludes the rights in the US and India, which were previously divested, and in Japan, which will be retained by AstraZeneca. The medicines, used Already a subscriber Login You…
Dignitana has partnered with ThermoTek to develop the DigniCap Delta, a model of the 2015 FDA-cleared DigniCap Scalp Cooling System. The new model is featuring a new single-patient use cap design and a smaller, more streamlined single-patient machine, reports the company. U.S. Food and Drug AdmiAlready a subscriber Login You have…
The license extension for Novo Nordisk’s Victoza® means the drug is now available to almost one million people in the UK who are affected by type 2 diabetes and moderate renal impairment. The decision by the European Commission (EC) means clinicians can treat patients with one daily injectAlready a subscriber Login You have read…
AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition will bolster AstraZeneca’s carAlready a subscriber Login You have read all your free articles, to continue…
